Evidence that heparin but not hirudin reduces PAI-1 expression in cultured human endothelial cells

Thrombosis Research

Volumn 94, Issue 3, 1999, Pages 137-145

  Orbe, Josune ^a   Montes, Ramón ^a   Zabalegui, Natalia ^a   Pérez Ruiz, Ana ^a   Páramo, José A ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Endotoxin; Heparin; Hirudin; HUVEC; mRNA; PAI 1

Indexed keywords

DESULFATOHIRUDIN; HEPARIN; PLASMINOGEN ACTIVATOR INHIBITOR;

ARTICLE; DRUG EFFECT; FIBRINOLYSIS; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA ANALYSIS; THROMBOSIS; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

EID: 0033136050     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(98)00203-5     Document Type: Article

References (41)

1. Erickson L.A., Schleef R.R., Ny T., Loskutoff D.J. The fibrinolytic system of vascular wall. Clin Haematol. 14:1985;513-530.
2. Aznar J., Estellés A. Role of plasminogen activator inhibitor type 1 in the pathogenesis of coronary artery disease. Haemostasis. 24:1994;243-251.
3. Rocha E., Páramo J.A. The relationship between impaired fibrinolysis and coronary heart disease. A role of PAI-1 Fibrinolysis. 8:1994;294-303.
4. Wiman B. Plasminogen activator inhibitor (PAI-1) in plasma. Its role in thrombotic disease Thromb Haemostas. 74:1995;71-76.
5. Fay W.P., Shapiro A.D., Shih J.L., Schleef R.D., Ginsburg D. Complete deficiency of plasminogen-activator inhibitor type 1 due to a frame-shift mutation. N Engl J Med. 327:1992;1729-1733.
6. Bartha K., Declerck P.J., Moreau H., Nelles L., Collen D. Synthesis and secretion of plasminogen activator inhitor 1 by human endothelial cells in vitro. J Biol Chem. 266:1991;792-797.
7. van Meijer M., Pannekoek H. Structure of plasminogen activator inhibitor 1 (PAI-1) and its function in fibrinolysis. An update Fibrinolysis. 9:1995;263-276.
8. Ginsburg D., Zeheb R., Yang A.Y., Rafferty U.M., Andreasen P.A., Nielsen L., Dano K., Lebo R.V., Gelehrter T.D. cDNA cloning of human plasminogen activator-inhibitor from endothelial cells. J Clin Invest. 78:1986;1673-1680.
9. Bosmat P.J., van den Berg E.A., Kooistra T., Siemieniak D.R., Slightom J.L. Human plasminogen activator inhibitor-1 gene. J Biol Chem. 263:1988;9129-9141.
10. Humphries S.E., Green F.R., Temple A., Dawson S., Henney A., Kelleher C.H., Wilkes H., Meade T.W., Wiman B., Hamsten A. Genetic factors determining thrombosis and fibrinolysis. Ann Epidemiol. 2:1992;371-385.
11. Colucci M., Páramo J.A., Collen D. Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation. J Clin Invest. 75:1985;814-824.
12. Pepper M.S., Ferrara N., Orci L., Montesano R. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun. 181:1991;902-906.
13. Schneider D.J., Nordt T.K., Sobel B.E. Stimulation by proinsulin of expression of plasminogen activator inhibitor type-1 in endothelial cells. Diabetes. 41:1992;890-895.
14. Loskutoff D.J., Sawdey M., Keeton M., Schneiderman J. Regulation of PAI-1 gene expression in vivo. J Biol Chem. 264:1989;10396-10401.
15. Vinazzer H.A., Stemberger A., Haas S., Blumel G. Influence of heparin of different heparin fractions and of molecular weight heparin-like substance on mechanism of fibrinolysis. Thromb Res. 27:1982;341-351.
16. Bounameaux H., Lijnen H.R., Hellemans H., Verstraete M. Effect of standard and low molecular weight heparin fractions on fibrinolysis and platelet aggregation in patiens undergoing histerectomy. Thromb Haemost. 55:1986;298.
17. Electricwala A., Atkinson T. Effect of hirudin on tissue plasminogen activator induced clot lysis. Blood Coag Fibrinol. 1:1990;267-271.
18. Clowes A.W., Clowes C.M., Kirkman T.R., Jackson C.L., Au Y.P.T., Kenagy R. Heparin inhibits the expression of tissue type plasminogen activator by smooth muscle cells in injured rat carotid artery. Circ Res. 70:1992;1128-1136.
19. Jaffe E.A., Nachmanm R.L., Becker C.G., Minick C.R. Cultured of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest. 52:1973;2745-2756.
20. Kuribayashi K., Hikata M., Hiraoka O., Miyamoto C., Furuicgi Y. A rapid and efficient purification of poly(A)-mRNA by oligo(dT)30-latex. Nucleic Acids Symp Ser. 19:1988;61-64.
21. Tso J.Y., Sun X.H., Kao T., Reece K.S., Wu R. Isolation and characterization of rat and human glyceraldehyde-3-phosphate deshydrogenase cDNAs. Genomic complexity and molecular evolution of the gen Nucleic Acids Res. 13:1985;2485-2502.
22. Mullis K.B., Faloona F.A. Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol. 155:1987;335-350.
23. Declerck P.J., Alessi M.C., Verstreken M., Kruithof E.K.O., Juhan-Vague Y., Collen D. Measurement of plasminogen activator inhibitor 1 in biological fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay. Blood. 71:1988;220-225.
24. Duplaa C., Counffinhal T., Labat L., Moreau C., Lamaziere J.D., Bonnet J. Quantitative analysis of polymerase chain reaction products using biotinylated dUTP incorporation. Anal Biochem. 212:1993;229-236.
25. Ma T.S., Brink P.A., Perryman B., Roberts R. Improved quantification with validation of multiple mRNA species by polymerase chain reaction. Application to human myocardial creatine kinase M and B Cardiovasc Res. 28:1994;464-471.
26. Verstraete M. Pharmacotherapeutic aspects of unfractionated and low molecular weight heparins. Drugs. 40:1990;498-530.
27. Cadroy Y., Gaspin D., Dupouy D., Lormeau J.C., Boneu B., Sié P. Heparin reverses the procoagulant properties of stimulated endothelial cells. Thromb Haemostas. 75:1996;190-195.
28. Gilchrist M., MacDonald A.J., Neverova I., Ritchie B., Befus A.D. Optimization of the isolation and effective use of mRNA from rat mast cells. J Immunol Methods. 201:1997;207-214.
29. Tsai M., Miyamoto M., Tam S.Y., Wang Z.S., Galli S.J. Detection of mouse mast cell-associated protease mRNA. Heparinase treatment greatly improves RT-PCR of tissues containing mast cell heparin. Am J Pathol. 146:1995;335-343.
30. Tannenbaum S.H., Chao E.S., Gralnick H.R. Heparin enhances endothelial cell von Willebrand factor content by growth factor dependent mechanisms. Thromb Haemostas. 72:1994;770-776.
31. Diquelou A., Dupouy D., Cariou R., Sakariassen K.S., Boneu B., Cadroy Y. A comparative study of the anticoagulant and anti-thrombotic effects of unfractionated heparin and low molecular weight heparin (Fraxiparine) in an experimental model of human venous thrombosis. Thromb Haemostas. 74:1995;1286-1292.
32. Justus A.C., Roussev R., Norcross J.L., Faulk W.P. Antithrombin binding by human umbilical vein endothelial cells. Effects of exogenous heparin Thromb Res. 79:1995;175-186.
33. Konkle B.A., Ginsburg D. The addition of endothelial cell growth factor and heparin to human umbilical vein endothelial cell cultures decreases plasminogen activator inhibitor-1 expression. J Clin Invest. 82:1988;579-585.
34. Minter A.J., Dawes J., Chesterman C.N. Effects of heparin and endothelial cell growth supplement on haemostatic functions of vascular endothelium. Thromb Haemostas. 67:1992;718-723.
35. Heaton J.H., Dame M.K., Gelehrter T.D. Thrombin induction of plasminogen activator inhibitor mRNA in human umbilical vein endothelial cells in culture. J Lab Clin Med. 120:1992;222-228.
36. van den Berg E.A., Sprengers E.D., Jaye M., Burgess W., Maciag T., van Hinsbergh V.W.M. Regulation of plasminogen activator inhibitor mRNA in human endothelial cells. Thromb Haemostas. 60:1988;63-67.
37. Chordá C., Páramo J.A., Rocha E. Comparison of the effects of unfractionated heparin, low molecular weight heparin and hirudin (Revasc) on the fibrinolytic potential of cultured umbilical vein endothelial cells. Fibrinolysis. 10:1996;43-48.
38. Cockell K.A., Ren S., Sun J., Angel A., Shen G.X. Effect of thrombin on release of plasminogen activator inhibitor-1 from cultured primate arterial smooth muscle cells. Thromb Res. 77:1995;119-131.
39. Biemond B.J., Levi M., ten-Cate H., Van-der-Poll T., Buller H.R., Hack C.E., ten-Cate J.W. Plasminogen activator and plasminogen activator inhibitor 1 release during experimental endotoxemia model in chimpanzees. Effect of interventions in citokine and coagulation cascades Clin Sci Colch. 88:1995;587-594.
40. Hermida J., Montes R., Páramo J.A., Rocha E. Endotoxin-induced disseminated intravascular coagulation in rabbits. Effect of recombinant hirudin on hemostatic parameters, fibrin deposits, and mortality J Lab Clin Med. 131:1998;77-83.
41. Soeda S., Fujii N., Shimeno H., Nagamatsu A. Oversulfated fucoidan and heparin supress endotoxin induction of plasminogen activator inhibitor-1 in cultured human endothelial cells. Their possible mechanism of action Biochim Biophys Acta. 1269:1995;85-90.